Colavita, F.; Castilletti, C.; Matusali, G.; Accordini, S.; De Masi, S.; Da Cas, R.; Gianesini, N.; Baglio, G.; Francalancia, M.; Traversa, G.;
et al. Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case–Control Study. Vaccines 2025, 13, 935.
https://doi.org/10.3390/vaccines13090935
AMA Style
Colavita F, Castilletti C, Matusali G, Accordini S, De Masi S, Da Cas R, Gianesini N, Baglio G, Francalancia M, Traversa G,
et al. Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case–Control Study. Vaccines. 2025; 13(9):935.
https://doi.org/10.3390/vaccines13090935
Chicago/Turabian Style
Colavita, Francesca, Concetta Castilletti, Giulia Matusali, Silvia Accordini, Salvatore De Masi, Roberto Da Cas, Natasha Gianesini, Giovanni Baglio, Massimo Francalancia, Giuseppe Traversa,
and et al. 2025. "Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case–Control Study" Vaccines 13, no. 9: 935.
https://doi.org/10.3390/vaccines13090935
APA Style
Colavita, F., Castilletti, C., Matusali, G., Accordini, S., De Masi, S., Da Cas, R., Gianesini, N., Baglio, G., Francalancia, M., Traversa, G., Chiarotti, F., Meschi, S., Bianco, E., Salomone, M., Mele, A., Messa, P., Zoccali, C., Menniti Ippolito, F., & the COVIDVaxDia Study Group.
(2025). Humoral Response to the Third Dose of SARS-CoV-2 Vaccine Among Dialysis Patients: A Breakthrough Infection Case–Control Study. Vaccines, 13(9), 935.
https://doi.org/10.3390/vaccines13090935
